We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Johnson & Johnson on Monday said it has acquired biopharmaceutical firm Intra-Cellular Therapies Inc for a total of a ...
UK claimants Wednesday announced legal action against US pharmaceutical and cosmetics firm Johnson & Johnson, allegin ...
Johnson & Johnson on Tuesday posted weaker earnings in the first quarter despite growing sales, as research and devel ...
Johnson & Johnson on Wednesday announced the completion of its USD600 million acquisition of heart failure treatment ...
Johnson & Johnson on Tuesday announced an acquisition for its MedTech division, as well as a US approval for its lung ...
Johnson & Johnson on Wednesday reported some sales progress in the second quarter, following the completion of its US ...
Johnson & Johnson on Friday completed its acquisition of Shockwave Medical Inc, enhancing the company's cardiovascula ...
Johnson & Johnson on Wednesday proposed a USD6.48 billion settlement of tens of thousands of lawsuits which allege th ...
Johnson & Johnson on Tuesday upped its dividend for the first quarter and upgraded its guidance, after swinging to ne ...
Johnson & Johnson on Friday boosted its cardiovascular portfolio with the USD13.1 billion acquisition of Shockwave Me ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5 | 3.48918353105 | 143.3 | 148.2 | 143.3 | 5765 | 145.83755984 | DE |
4 | 4.5 | 3.12934631433 | 143.8 | 148.2 | 141.5 | 6555 | 144.47869893 | DE |
12 | -13.1 | -8.11648079306 | 161.4 | 161.4 | 141.5 | 43961 | 150.91769265 | DE |
26 | -6.4 | -4.13703943116 | 154.7 | 167.7 | 141.5 | 28222 | 154.94024739 | DE |
52 | -13.7 | -8.45679012346 | 162 | 167.7 | 141.5 | 81559 | 158.50816376 | DE |
156 | -18.7 | -11.1976047904 | 167 | 185.96 | 141.5 | 114130 | 162.07528586 | DE |
260 | -1.65 | -1.10036678893 | 149.95 | 185.96 | 111.87 | 84597 | 161.81727882 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions